Immune suppression gene on HLA-Bw54-DR4-DRw53 haplotype controls nonresponsiveness in humans to hepatitis B surface antigen via CD8+ suppressor T cells

Hiroshi Watanabe, Sho Matsushita, Nobuhiro Kamikawaji, Kenji Hirayama, Makoto Okumura, Takehiko Sasazuki

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

The development of antiviral vaccines has been accelerated using monoclonal antibody and/or recombinant DNA techniques, the objective being to prevent grave viral infectious diseases, such as acquired immunodeficiency syndrome (AIDS), adult T-cell leukemia (ATL), and hepatitis B virus (HBV)-associated liver diseases. Certain proportions of individuals in the human population do not have any appreciable immune response to foreign antigens, either in cases of natural exposure or a planned immunization. Here we report that in the nonresponders to HB vaccine, there is an HLA-linked immune suppression gene for hepatitis B surface antigen (Is-HBsAg) controlling the nonresponsiveness to HBsAg through HBsAg-specific suppressor T cells. The Is-HBsAg is in strong linkage disequilibrium with the HLA-Bw54-DR4-DRw53 haplotype.

Original languageEnglish
Pages (from-to)9-17
Number of pages9
JournalHuman Immunology
Volume22
Issue number1
DOIs
Publication statusPublished - Jan 1 1988

Fingerprint

HLA-DR4 Antigen
Hepatitis B Surface Antigens
Haplotypes
T-Lymphocytes
Genes
Vaccines
Adult T Cell Leukemia Lymphoma
Recombinant DNA
Linkage Disequilibrium
Virus Diseases
Hepatitis B virus
Antiviral Agents
Communicable Diseases
Liver Diseases
Immunization
Acquired Immunodeficiency Syndrome
Monoclonal Antibodies
Antigens
HLA-B54 antigen
Population

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Immune suppression gene on HLA-Bw54-DR4-DRw53 haplotype controls nonresponsiveness in humans to hepatitis B surface antigen via CD8+ suppressor T cells. / Watanabe, Hiroshi; Matsushita, Sho; Kamikawaji, Nobuhiro; Hirayama, Kenji; Okumura, Makoto; Sasazuki, Takehiko.

In: Human Immunology, Vol. 22, No. 1, 01.01.1988, p. 9-17.

Research output: Contribution to journalArticle

Watanabe, Hiroshi ; Matsushita, Sho ; Kamikawaji, Nobuhiro ; Hirayama, Kenji ; Okumura, Makoto ; Sasazuki, Takehiko. / Immune suppression gene on HLA-Bw54-DR4-DRw53 haplotype controls nonresponsiveness in humans to hepatitis B surface antigen via CD8+ suppressor T cells. In: Human Immunology. 1988 ; Vol. 22, No. 1. pp. 9-17.
@article{57cafc0b1c0042c880504d06be0c1098,
title = "Immune suppression gene on HLA-Bw54-DR4-DRw53 haplotype controls nonresponsiveness in humans to hepatitis B surface antigen via CD8+ suppressor T cells",
abstract = "The development of antiviral vaccines has been accelerated using monoclonal antibody and/or recombinant DNA techniques, the objective being to prevent grave viral infectious diseases, such as acquired immunodeficiency syndrome (AIDS), adult T-cell leukemia (ATL), and hepatitis B virus (HBV)-associated liver diseases. Certain proportions of individuals in the human population do not have any appreciable immune response to foreign antigens, either in cases of natural exposure or a planned immunization. Here we report that in the nonresponders to HB vaccine, there is an HLA-linked immune suppression gene for hepatitis B surface antigen (Is-HBsAg) controlling the nonresponsiveness to HBsAg through HBsAg-specific suppressor T cells. The Is-HBsAg is in strong linkage disequilibrium with the HLA-Bw54-DR4-DRw53 haplotype.",
author = "Hiroshi Watanabe and Sho Matsushita and Nobuhiro Kamikawaji and Kenji Hirayama and Makoto Okumura and Takehiko Sasazuki",
year = "1988",
month = "1",
day = "1",
doi = "10.1016/0198-8859(88)90047-X",
language = "English",
volume = "22",
pages = "9--17",
journal = "Human Immunology",
issn = "0198-8859",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Immune suppression gene on HLA-Bw54-DR4-DRw53 haplotype controls nonresponsiveness in humans to hepatitis B surface antigen via CD8+ suppressor T cells

AU - Watanabe, Hiroshi

AU - Matsushita, Sho

AU - Kamikawaji, Nobuhiro

AU - Hirayama, Kenji

AU - Okumura, Makoto

AU - Sasazuki, Takehiko

PY - 1988/1/1

Y1 - 1988/1/1

N2 - The development of antiviral vaccines has been accelerated using monoclonal antibody and/or recombinant DNA techniques, the objective being to prevent grave viral infectious diseases, such as acquired immunodeficiency syndrome (AIDS), adult T-cell leukemia (ATL), and hepatitis B virus (HBV)-associated liver diseases. Certain proportions of individuals in the human population do not have any appreciable immune response to foreign antigens, either in cases of natural exposure or a planned immunization. Here we report that in the nonresponders to HB vaccine, there is an HLA-linked immune suppression gene for hepatitis B surface antigen (Is-HBsAg) controlling the nonresponsiveness to HBsAg through HBsAg-specific suppressor T cells. The Is-HBsAg is in strong linkage disequilibrium with the HLA-Bw54-DR4-DRw53 haplotype.

AB - The development of antiviral vaccines has been accelerated using monoclonal antibody and/or recombinant DNA techniques, the objective being to prevent grave viral infectious diseases, such as acquired immunodeficiency syndrome (AIDS), adult T-cell leukemia (ATL), and hepatitis B virus (HBV)-associated liver diseases. Certain proportions of individuals in the human population do not have any appreciable immune response to foreign antigens, either in cases of natural exposure or a planned immunization. Here we report that in the nonresponders to HB vaccine, there is an HLA-linked immune suppression gene for hepatitis B surface antigen (Is-HBsAg) controlling the nonresponsiveness to HBsAg through HBsAg-specific suppressor T cells. The Is-HBsAg is in strong linkage disequilibrium with the HLA-Bw54-DR4-DRw53 haplotype.

UR - http://www.scopus.com/inward/record.url?scp=0023908785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023908785&partnerID=8YFLogxK

U2 - 10.1016/0198-8859(88)90047-X

DO - 10.1016/0198-8859(88)90047-X

M3 - Article

C2 - 2968966

AN - SCOPUS:0023908785

VL - 22

SP - 9

EP - 17

JO - Human Immunology

JF - Human Immunology

SN - 0198-8859

IS - 1

ER -